Financial Performance - Q3 2024 revenue was CNY 50,185,955.72, a decrease of 14.25% year-over-year[2] - Net profit attributable to shareholders was CNY -3,559,065.62, an increase of 35.78% compared to the same period last year[2] - Net profit excluding non-recurring items was CNY -6,490,065.55, down 16.87% year-over-year[2] - Total operating revenue for the current period is ¥155,994,341.01, a decrease of 13.3% from ¥179,935,611.58 in the previous period[13] - Operating profit for the current period is -¥15,605,304.74, an improvement from -¥46,327,062.16 in the previous period[14] - Net profit for the current period is -¥15,532,421.60, compared to -¥46,056,930.81 in the previous period, indicating a significant reduction in losses[14] - Total comprehensive loss for the current period is -¥15,532,421.60, compared to -¥46,056,930.81 in the previous period, reflecting improved financial performance[14] Cash Flow - Cash flow from operating activities was CNY 722,857.64, an increase of 34.26% year-to-date[5] - Operating cash inflow for the period was CNY 165,801,061.54, a decrease of 18.6% from CNY 203,759,956.42 in the previous period[15] - Cash outflow from operating activities totaled CNY 165,078,203.90, down 18.7% from CNY 203,221,542.03 year-on-year[15] - Net cash flow from operating activities increased to CNY 722,857.64, compared to CNY 538,414.39 in the same period last year, reflecting a growth of 34.2%[15] - Cash flow from investing activities showed a net outflow of CNY 2,103,168.58, worsening from a net outflow of CNY 1,784,238.50 in the previous year[15] - Cash inflow from financing activities was CNY 6,000,000.00, down 62.5% from CNY 16,000,000.00 in the prior period[16] - Net cash flow from financing activities decreased to -CNY 6,526,251.44, compared to -CNY 6,277,458.00 in the same period last year[16] - The ending balance of cash and cash equivalents was CNY 10,971,103.42, down 45.6% from CNY 20,210,996.60 at the end of the previous period[16] Assets and Liabilities - Total assets at the end of the period were CNY 649,603,945.11, a decrease of 1.72% from the end of the previous year[2] - Total liabilities increased from RMB 148,194,542.06 to RMB 152,355,874.28, an increase of about 2.9%[11] - The total equity attributable to the parent company decreased from RMB 481,706,954.69 to RMB 467,089,798.90, a decline of approximately 3.03%[12] - The company reported a net loss of RMB 636,509,152.18 in retained earnings, worsening from a loss of RMB 621,891,996.39[11] - Current assets increased slightly from RMB 509,380,002.54 to RMB 510,639,379.91, an increase of about 0.25%[10] - Cash and cash equivalents decreased from RMB 18,927,001.92 to RMB 14,404,775.85, a decline of approximately 23.5%[10] - Accounts receivable decreased from RMB 69,818,340.96 to RMB 62,855,957.03, a decrease of about 10%[10] - Inventory increased from RMB 408,528,324.96 to RMB 409,541,818.90, an increase of approximately 0.25%[10] Shareholder Information - The number of ordinary shareholders at the end of the period was 100,681[6] - The largest shareholder, Yu Qinfeng, holds 14.32% of the shares, totaling 147,381,643 shares[6] Expenses - Research and development expenses for the current period are ¥20,697,253.25, slightly down from ¥21,816,849.53 in the previous period[13] - Sales expenses decreased to ¥56,857,787.86, down 37.0% from ¥90,286,488.06 in the previous period[13] - Management expenses decreased to ¥42,952,796.62, down 11.5% from ¥48,366,970.55 in the previous period[13] - Other income for the current period is ¥3,328,234.09, compared to ¥482,001.89 in the previous period, showing a significant increase[14] Other Information - The company has no long-term borrowings or bonds payable reported[11] - The company continues to invest in construction projects, with construction in progress increasing from RMB 3,936,000.00 to RMB 6,712,400.00[11] - The report for the third quarter was not audited[17] - The company is set to implement new accounting standards starting in 2024, which may affect future financial reporting[16]
四环生物(000518) - 2024 Q3 - 季度财报